PMID: 42285215

Plasma metabolomics enhances risk prediction for lung cancer: a population-based validation study.

Wang Chenran, Dong Xuesi, Zhang Guochao, Ren Na, Chen Xiaolu, Xie Jiaxin, Shi Xiaoyue, Guo Zeming, Zheng Yadi, Luo Zilin

Cancer letters · 2026

Vol. 656, pp. 218676

View on PubMedDOI

This entry links to third-party literature. For research use only.

For research use only. This index links to third-party literature. Nothing here constitutes medical advice.